News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
86,005 Results
Type
Article (3546)
Company Profile (14)
Press Release (82441)
Multimedia
Podcasts (8)
Webinars (3)
Section
Business (23062)
Career Advice (165)
Deals (3541)
Drug Delivery (12)
Drug Development (10858)
Employer Resources (19)
FDA (2228)
Job Trends (1945)
News (39036)
Policy (2553)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (320)
Accelerated approval (4)
Adcomms (4)
Allergies (18)
Alliances (8328)
ALS (32)
Alzheimer's disease (226)
Antibody-drug conjugate (ADC) (84)
Approvals (2282)
Artificial intelligence (207)
Autoimmune disease (28)
Automation (10)
Bankruptcy (16)
Best Places to Work (1766)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (14)
Bladder cancer (20)
Brain cancer (13)
Breast cancer (153)
Cancer (1057)
Cardiovascular disease (81)
Career advice (142)
Career pathing (2)
CAR-T (72)
CDC (6)
Cell therapy (166)
Cervical cancer (4)
Clinical research (9562)
Collaboration (450)
Compensation (66)
Complete response letters (6)
COVID-19 (337)
CRISPR (23)
C-suite (109)
Cystic fibrosis (25)
Data (1361)
Denatured (3)
Depression (22)
Diabetes (74)
Diagnostics (1205)
Digital health (10)
Diversity (3)
Diversity, equity & inclusion (4)
Drug discovery (73)
Drug pricing (14)
Drug shortages (3)
Duchenne muscular dystrophy (39)
Earnings (9243)
Editorial (5)
Employer branding (1)
Employer resources (16)
Events (11463)
Executive appointments (152)
FDA (2809)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (268)
Gene editing (60)
Generative AI (21)
Gene therapy (160)
GLP-1 (153)
Government (402)
Grass and pollen (1)
Guidances (97)
Healthcare (2809)
HIV (2)
Huntington's disease (7)
IgA nephropathy (23)
Immunology and inflammation (44)
Immuno-oncology (5)
Indications (21)
Infectious disease (366)
Inflammatory bowel disease (37)
Inflation Reduction Act (3)
Influenza (16)
Intellectual property (38)
Interviews (22)
IPO (1618)
IRA (8)
Job creations (243)
Job search strategy (115)
JPM (14)
Kidney cancer (5)
Labor market (13)
Layoffs (75)
Leadership (3)
Legal (232)
Liver cancer (10)
Longevity (5)
Lung cancer (123)
Lymphoma (80)
Machine learning (17)
Management (10)
Manufacturing (174)
MASH (24)
Medical device (2310)
Medtech (2322)
Mergers & acquisitions (2109)
Metabolic disorders (195)
Multiple sclerosis (22)
NASH (2)
Neurodegenerative disease (52)
Neuropsychiatric disorders (15)
Neuroscience (432)
NextGen: Class of 2026 (908)
Non-profit (484)
Now hiring (4)
Obesity (83)
Opinion (52)
Ovarian cancer (37)
Pain (30)
Pancreatic cancer (39)
Parkinson's disease (62)
Partnered (12)
Patents (66)
Patient recruitment (110)
Peanut (8)
People (5531)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase 1 (3594)
Phase 2 (4469)
Phase 3 (2688)
Pipeline (1208)
Policy (26)
Postmarket research (216)
Preclinical (1403)
Press Release (21)
Prostate cancer (72)
Psychedelics (9)
Radiopharmaceuticals (66)
Rare diseases (127)
Real estate (585)
Recruiting (7)
Regulatory (2512)
Reports (13)
Research institute (306)
Resumes & cover letters (35)
Rett syndrome (10)
RNA editing (4)
RSV (6)
Schizophrenia (28)
Series A (39)
Series B (37)
Service/supplier (1)
Sickle cell disease (13)
Special edition (2)
Spinal muscular atrophy (21)
Sponsored (13)
Startups (444)
Stomach cancer (1)
Supply chain (18)
Tariffs (8)
The Weekly (5)
Vaccines (91)
Venture capital (18)
Weight loss (42)
Women's health (15)
Worklife (1)
Date
Last 7 days (101)
Last 30 days (345)
Last 365 days (5455)
2026 (471)
2025 (5579)
2024 (6322)
2023 (6332)
2022 (7179)
2021 (7767)
2020 (7491)
2019 (7043)
2018 (5113)
2017 (4224)
2016 (3681)
2015 (4370)
2014 (2963)
2013 (2341)
2012 (2475)
2011 (2614)
2010 (2140)
Location
Africa (54)
Alabama (37)
Alaska (1)
Arizona (45)
Arkansas (3)
Asia (4809)
Australia (914)
California (1762)
Canada (551)
China (231)
Colorado (113)
Connecticut (64)
Delaware (52)
Europe (15095)
Florida (299)
Georgia (49)
Idaho (13)
Illinois (162)
India (13)
Indiana (117)
Iowa (12)
Japan (70)
Kansas (53)
Kentucky (5)
Louisiana (6)
Maine (12)
Maryland (229)
Massachusetts (1573)
Michigan (94)
Minnesota (89)
Missouri (20)
Montana (4)
Nebraska (5)
Nevada (15)
New Hampshire (27)
New Jersey (442)
New Mexico (6)
New York (611)
North Carolina (212)
North Dakota (1)
Northern California (907)
Ohio (71)
Oklahoma (3)
Oregon (7)
Pennsylvania (456)
Puerto Rico (6)
Rhode Island (9)
South America (94)
South Carolina (11)
South Dakota (1)
Southern California (637)
Tennessee (55)
Texas (348)
United States (7062)
Utah (58)
Virginia (43)
Washington D.C. (8)
Washington State (162)
Wisconsin (22)
Wyoming (1)
86,005 Results for "optim".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
Stop Optimizing Your Job, Start Optimizing Your Career
The difference between a job and a career is what you walk away with when it ends. Here’s how to evaluate if your role and environment are enabling capability building–and if your title is holding you back.
December 11, 2025
·
5 min read
·
Angela Justice
IPO
Eikon, Veradermics, Announce IPO Targets as Cautious Optimism Propels Biotech Market
Cancer-focused Eikon Therapeutics is seeking $273.5 million in its bid to trade on the Nasdaq, while hair growth specialist Veradermics is looking for $181.1 million in its foray onto the New York Stock Exchange.
January 29, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Bayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization
January 7, 2026
·
4 min read
Press Releases
GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million
January 21, 2026
·
3 min read
Press Releases
Bicara Therapeutics Announces Phase 3 Optimal Dose and Provides 2026 Corporate Outlook
January 12, 2026
·
9 min read
Press Releases
Sysmex America Expands CN™-Series with CN-9000 to Help Labs of All Sizes Optimize Workflow
January 22, 2026
·
2 min read
Press Releases
Alligator Bioscience to Present New OPTIMIZE-1 Data on Mitazalimab at ASCO Gastrointestinal Cancers Symposium 2026
January 9, 2026
·
2 min read
Press Releases
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
January 8, 2026
·
5 min read
Press Releases
Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™
October 9, 2025
·
4 min read
Press Releases
CellCentric Presents Positive Phase 2 Dose Optimization Data for Inobrodib in Multiple Myeloma at ASH Annual Meeting
- Inobrodib in combination with pomalidomide + dexamethasone (InoPd) demonstrates strong clinical efficacy and a tolerable safety profile in heavily pretreated relapsed/refractory multiple myeloma (RRMM) patients - - Observed response rates of 60-75% with inobrodib 20 mg and 30 mg cohorts result in clinical efficacy at least two-fold higher than previously published real-world data for pom-refractory, bispecific or anti-BCMA exposed patients -
December 9, 2025
·
4 min read
1 of 8,601
Next